Ottowa Hospital Research Institute is assisting with events relative to withdrawal of life-sustaining therapy.
Ottowa Hospital Research Institute is assisting with decisions associated with events relative to withdrawal of life-sustaining therapy. The system can determine the probability of death (or inadequate organ perfusion) within a certain time frame after withdrawal of life-sustaining therapy. These estimates can reduce the distress of the patients families, as well as optimize the use of resources surrounding donation.
Related Posts
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…